• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Acton

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    Eolas Medical raises £9m Series A led by Acton Capital to give healthcare professionals access to on-demand medical knowledgeEolas Medical raises £9m Series A led by Acton Capital to give healthcare professionals access to on-demand medical knowledge
    Eolas Medical
    21 Jan 2026

    Eolas Medical raises £9m Series A led by Acton Capital to give healthcare professionals access to on-demand medical knowledge

    Eolas Medical provides a clinical knowledge platform that gives healthcare professionals instant access to local guidelines, protocols and pathways at the point of care.

    Stotles lands £10m Series A led by Headline and Acton to transform how companies win public sector contractsStotles lands £10m Series A led by Headline and Acton to transform how companies win public sector contracts
    Stotles
    29 May 2025

    Stotles lands £10m Series A led by Headline and Acton to transform how companies win public sector contracts

    Stotles builds a platform that helps private companies identify, qualify and bid for public sector contracts, using data and AI to focus teams on realistic revenue opportunities.

Acton
    • Health
    • Sales
  • 1(12 months)
  • actoncapital.com
  • Update Information

More venture news

  • Capsa AI lands £14m Series A led by TX Ventures and Pivot Investment Partners to build the AI operating system for private capital
    Capsa AI
    10 Jun 2026

    Capsa AI lands £14m Series A led by TX Ventures and Pivot Investment Partners to build the AI operating system for private capital

    Series AAI
  • NewOrbit raises £14m in a Series A led by Voyager Ventures to build the first commercial satellites for very low Earth orbit
    NewOrbit
    9 Jun 2026

    NewOrbit raises £14m in a Series A led by Voyager Ventures to build the first commercial satellites for very low Earth orbit

    Series ADeep Tech
  •  IMU Biosciences unlocks £40m Series A led by IQ Capital and Molten Ventures to decode the immune system with high-resolution blood analysis
    IMU Biosciences
    2 Jun 2026

    IMU Biosciences unlocks £40m Series A led by IQ Capital and Molten Ventures to decode the immune system with high-resolution blood analysis

    Series ALife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn